Primrose Therapeutics Competitors and Similar CompaniesClear all

Primrose Therapeutics's competitors and similar companies include CHF Solutions, Spero Therapeutics, EnClear Therapies and MicrofluidX.
Primrose Therapeutics
Primrose Therapeutics
Primrose Therapeutics is engaged in the development of treatments for polycystic kidney disease.
CHF Solutions
CHF Solutions
CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients.
Spero Therapeutics
Spero Therapeutics
Spero Therapeutics is a biopharmaceutical company developing a pipeline of novel treatments for bacterial infections.
EnClear Therapies
EnClear Therapies
EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases.
MicrofluidX
MicrofluidX
MicrofluidX is a company that develops cell bioprocessing technology.
Founding Date
Founding Date
N/A
Founding Date
1999
Founding Date
2013
Founding Date
2018
Founding Date
2018
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
New York, US HQ
Locations
Eden Prairie, US HQ
Locations
Cambridge, US HQ
Locations
Newburyport, US HQ
Locations
HQ
Employees
Employees
1
Employees
6620% increase
Employees
5739% increase
Employees
11
Employees
405% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
34.5 m
Valuation ($)
70.8 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$8.3m (FY, 2025)
Revenue (est.)
$66.8m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($17.5m) (FY, 2025)
Net income
$8.6m (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 752.6k (almost 16 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 10m (over 6 years ago)
Latest funding round
$ 1.7m (about 6 years ago)
Total funding raised
Total funding raised
$ 752.6k
Total funding raised
$ 9m
Total funding raised
$ 121.5m
Total funding raised
$ 12m
Total funding raised
$ 1.7m
For sources of this data, please see the company profile

View Company Profiles

CHF Solutions
HQ
Eden Prairie, US
Employees
66↑ 20% increase

CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients.

View company
Spero Therapeutics
HQ
Cambridge, US
Employees
57↑ 39% increase

Spero Therapeutics is a biopharmaceutical company developing a pipeline of novel treatments for bacterial infections.

View company
EnClear Therapies
HQ
Newburyport, US
Employees
11

EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases.

View company
MicrofluidX
HQ
Employees
40↓ 5% decrease

MicrofluidX is a company that develops cell bioprocessing technology.

View company